The MAP4K4-specific inhibitor GNE-495 exerts multiple therapeutic effects against pancreatic cancer, including inhibiting cell proliferation, inducing apoptosis, and reducing tumour stroma. The gene discussed is MAP4K4; the disease is familial pancreatic carcinoma.